Supplements for Cognitive Decline: What Older Adults Should Know

A small number of supplements have real human trial evidence behind them for cognitive decline in older adults. A much larger group is popular but unsupported. Knowing the difference determines whether you spend money on something that helps or something that does nothing.

Cognitive decline covers a range, from the ordinary slowing that comes with age to mild cognitive impairment (MCI) and dementia. The right supplement conversation depends on where someone falls on that range, and it starts with what the evidence actually supports rather than what marketing claims.

What Supplements Actually Help with Cognitive Decline?

Daily multivitamins, omega-3 fatty acids, vitamin D, and citicoline are the options with the most direct human trial support for cognitive decline in older adults. Ginkgo biloba, high-dose antioxidants, and several other popular ingredients have been tested in large trials and have not held up.

The evidence for each ingredient varies by how strong the studies are, who was studied, and what outcome was measured. A supplement that improves memory scores in a healthy 65-year-old is not the same evidence as one tested in people with diagnosed Alzheimer’s disease. The sections below break down what has been tested, in whom, and with what result.

Before starting any supplement regimen, it is worth discussing the options with a healthcare provider, especially given the medication interactions covered later in this article.

The Strongest Evidence: Daily Multivitamins and the COSMOS Trial

The COSMOS trial is the largest and most rigorous test to date of a daily multivitamin-mineral supplement for cognitive aging, and it found a measurable benefit in older adults.

The trial followed thousands of older adults over multiple years and assessed memory and global cognition through several substudies. COSMOS co-director Dr. JoAnn Manson summarized the finding by noting that a daily multivitamin improved memory and slowed cognitive decline in two separate studies within the trial, calling multivitamin supplementation a safe, accessible way to support cognitive health in midlife and older adults.

This is one of the few supplement findings in this space that comes from a large, well-controlled, multi-year randomized trial rather than a small pilot study or an observational association. That distinction matters. Multivitamins are inexpensive, widely available, and carry a low risk profile for most healthy older adults, which is part of why this finding has drawn attention.

The result does not mean every multivitamin brand or formulation produces the same effect, since the trial tested a specific product. It also does not mean a multivitamin reverses existing cognitive decline. It slowed the rate of decline in the study population over the trial period.

Omega-3 Fatty Acids and Age-Related Cognitive Decline

Omega-3 supplementation shows mixed results for cognitive decline, with the evidence depending heavily on which population was studied.

Randomized, placebo-controlled trials testing DHA, the primary omega-3 fatty acid in the brain, have produced inconsistent findings. A 2010 trial published in JAMA by Quinn and colleagues found that DHA supplementation did not slow cognitive decline in people already diagnosed with Alzheimer’s disease, while other trials in healthy older adults with age-related cognitive decline have shown more encouraging results. A systematic review covering both studies concluded that the efficacy of DHA supplementation remains mixed across trial populations.

The pattern that emerges is this: omega-3s appear more promising as a preventive measure in cognitively healthy older adults than as a treatment once dementia has been diagnosed. The right form and dose of omega-3s for brain health varies by individual factors like existing intake and diagnosis status, which is why matching the supplement to the specific goal matters more than simply taking fish oil.

Vitamin D, B Vitamins, and Deficiency-Driven Decline

Vitamin D and B vitamins matter most for cognitive decline when someone has an actual deficiency. Supplementing without a confirmed shortfall has much weaker support.

A 2010 study in the Archives of Internal Medicine by Llewellyn and colleagues followed elderly adults for six years and found that low vitamin D levels were associated with substantial cognitive decline in that population, a finding the authors said raised new possibilities for treatment and prevention. A blood test is the only reliable way to confirm a deficiency, and a healthcare provider can recommend the right dose if one is found.

B vitamins carry a more mixed picture than many marketing claims suggest. A 2012 systematic review by O’Leary and colleagues in the British Journal of Nutrition, covering 35 prospective studies and more than 14,000 participants, concluded that the evidence does not support a role for low vitamin B12 in the development of cognitive impairment or dementia at a population level. This does not rule out a benefit for someone with a diagnosed B12 deficiency, which has its own well-established neurological effects. It means B12 supplementation is not a general cognitive-decline treatment for people with normal levels.

The connection between B12, folate, and cognitive function is confirmed through routine bloodwork, since symptoms alone rarely distinguish a true deficiency from normal aging, and why these two nutrients matter for cognitive function is a distinction worth ruling in or out early.

Citicoline: An Overlooked Option for Aging Brains

Citicoline, also called CDP-choline, has human trial evidence specifically in healthy older adults with age-related memory complaints, an evidence angle most brain-supplement content overlooks.

A 2021 randomized, double-blind, placebo-controlled trial published in The Journal of Nutrition by Nakazaki and colleagues found that 12 weeks of citicoline supplementation improved overall memory performance, particularly episodic memory (the ability to recall specific events and experiences), in healthy older adults with age-associated memory impairment.

This is a promising result rather than a settled one. It comes from a single trial in a specific population, and larger studies are needed to confirm the effect and establish an optimal dose. Citicoline also has separate trial evidence in stroke recovery and neuroprotection, which is a different use case from general memory support in aging.

Use the generic name citicoline when researching this ingredient. Clinical evidence applies to the compound itself, not a specific brand. Citicoline and alpha-GPC, the two most common choline sources in brain supplements differ in bioavailability and dosing, a distinction that matters once someone decides to try a choline-based option for memory support.

Ginkgo Biloba, Antioxidants, and Other Popular but Unproven Options

Ginkgo biloba is among the most widely marketed brain supplements for older adults, and the largest trial ever conducted on it found no benefit for preventing dementia.

The Ginkgo Evaluation of Memory (GEM) study, led by Dr. Steven T. DeKosky and summarized by the National Center for Complementary and Integrative Health, followed participants at four clinical sites over eight years. It found that 240 milligrams per day of ginkgo biloba was ineffective in reducing the development of dementia and Alzheimer’s disease in older people. This remains the largest clinical trial ever to evaluate ginkgo’s effect on dementia occurrence.

Antioxidants such as vitamin C and vitamin E show associations with lower cognitive decline risk in some observational research. Observational data cannot establish that the antioxidants themselves caused the difference, since other factors common to people who take antioxidant supplements, including diet quality and overall health status, could account for the pattern. Phosphatidylserine and acetyl-L-carnitine have some smaller positive trials but need larger, independent replication before the evidence can be called strong.

Ginkgo biloba’s effect on memory across the wider trial record remains underwhelming beyond the GEM study, with similar null results reported in smaller trials testing different doses and populations.

Normal Aging, Mild Cognitive Impairment, or Something More?

Mild cognitive impairment sits in the space between typical age-related forgetfulness and dementia, and where someone falls on that spectrum changes which conversations and interventions make sense.

The National Institute on Aging describes MCI as a condition in which people have more memory or thinking problems than other people their age, while noting that someone with MCI can usually still take care of themselves and carry out normal daily activities. Dementia involves cognitive changes severe enough to interfere with daily life and independence.

Ordinary age-related forgetfulness looks different from both. Misplacing keys occasionally or needing an extra moment to recall a name is common and typically not a cause for concern on its own. Losing things often, missing important appointments, or struggling noticeably more than peers with word-finding are signs that a formal evaluation for MCI is worth pursuing.

A doctor can run cognitive screening tests and order bloodwork to rule out reversible contributors like thyroid dysfunction or vitamin deficiencies before assuming a decline is progressive. This distinction is also why the supplement evidence in this article, most of it studied in healthy older adults or those with mild age-related complaints, does not automatically transfer to someone with diagnosed dementia.

Supplement Safety for Older Adults: Interactions, Polypharmacy, and What to Watch For

Older adults face a higher risk of supplement-drug interactions than younger adults, largely because they are more likely to be taking multiple prescription medications at once.

Johns Hopkins Medicine warns that herbal preparations and nutritional supplements are aggressively marketed to older adults with exaggerated claims and little scientific evidence, and that these products can interact with prescription medicines and cause side effects. This risk compounds with each additional medication or supplement someone takes, a pattern known as polypharmacy.

Fish oil and other omega-3 supplements can increase bleeding risk when combined with blood thinners. High-dose vitamin E carries a similar concern. Some botanical supplements interact with common medications for blood pressure, blood sugar, or mood. None of this means supplements are inherently unsafe, but it means the calculation is different for someone on five prescriptions than for someone on none.

If you take medication for a chronic condition or you are caring for someone who does, bring a full list of current medications and supplements to a healthcare provider before adding anything new. A pharmacist can also run an interaction check quickly and is often an underused resource for this specific question.

What Supplements Can’t Do for Cognitive Decline

No supplement reverses established dementia, and none has been shown to prevent it outright. A small number of supplements may support cognitive health or modestly slow age-related decline in specific populations. None of them cure or stop a progressive disease.

The strongest findings in this article, the COSMOS multivitamin result and the citicoline memory trial, come from healthy older adults or those with mild, age-related complaints. They do not tell us what happens in someone with moderate or advanced dementia, where the underlying brain changes are more extensive. Supplements also work slowly, if they work at all. Anyone expecting a noticeable change within days or weeks is likely to be disappointed regardless of which product they choose.

Sustained or worsening symptoms usually trace back to an identifiable driver, and what works, what doesn’t, and why it matters across the full range of brain and memory supplements is worth understanding as the broader framework this specific question sits within.

If cognitive symptoms are new, worsening, or affecting daily function, a doctor can identify the cause and rule out treatable contributors before supplements are even part of the conversation.